New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...

MediLink Therapeutics Ltd. is exploring a licensing partnership to develop an antibody-drug conjugate with a global ...

Mark Millich, 26 years old and insecure about his thinning hair, was curious about the ads he saw promising to reverse his ...

From DoorDash to Warby Parker, plenty of successful founders got their start at consulting firms like Bain and McKinsey.

Versatope Therapeutics Incorporated, a biotechnology company developing vaccines and immuno-therapeutics announced today Edward Jordan and Sam Rasty have joined the company's Board of Directors and ...

Molson Coors, Merck & Co. and Deutsche Telekom are part ... Anheuser-Busch InBev (BUD), Molson Coors (TAP), and Boston Beer Company (SAM). Over 60% of Americans say they drink alcohol, so beer ...

That rise came despite the approval of Merck & Co's 15-valent Vaxneuvance ... and broadens GSK's existing scientific footprint in the Boston area," said GSK's R&D chief Hal Barron.

Merck says the expansion in Durham is part of more than $12 billion the company has invested in U.S. manufacturing and ...

March 11 (Reuters) - A federal judge ruled in favor of Merck (MRK.N), opens new tab in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers ...

Celonic Group, a Swiss-based CDMO, is integrating Merck’s Breez™ micro-bioreactor platform into its process development operations. This addition will further enhance Celonic’s capabilities ...